CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 81 filers reported holding CTI BIOPHARMA CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,684,404 | $21,876,000 | 9.07% |
| Lion Point Capital, LP | 5,489,546 | $25,636,000 | 5.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,250,000 | $10,508,000 | 4.35% |
| Bleichroeder LP | 3,859,707 | $18,025,000 | 3.20% |
| NEA Management Company, LLC | 7,140,450 | $99,804,000 | 2.88% |
| BVF INC/IL | 8,929,690 | $41,702,000 | 1.67% |
| Ghost Tree Capital, LLC | 1,300,000 | $6,071,000 | 1.32% |
| EAM Investors, LLC | 1,011,935 | $4,726,000 | 0.88% |
| Knott David M Jr | 556,687 | $2,600,000 | 0.83% |
| Sofinnova Investments, Inc. | 1,952,691 | $9,119,000 | 0.69% |